Technical Analysis for ILMN - Illumina, Inc.

Grade Last Price % Change Price Change
D 122.87 -1.28% -1.59
ILMN closed down 1.28 percent on Wednesday, April 24, 2024, on 77 percent of normal volume.
Earnings due: May 2
*** please verify all earnings dates ***
4 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Up

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Gapped Down Weakness 0.00%
Up 3 Days in a Row Strength -1.28%
Oversold Stochastic Weakness -1.28%
Multiple of Ten Bullish Other 2.18%
Oversold Stochastic Weakness 2.18%
Stochastic Buy Signal Bullish 4.63%
NR7 Range Contraction 4.63%
Lower Bollinger Band Walk Weakness 4.63%
Oversold Stochastic Weakness 4.63%

   Recent Intraday Alerts

Alert Time
10 DMA Support about 8 hours ago
Fell Below 10 DMA about 8 hours ago
60 Minute Opening Range Breakdown about 9 hours ago
Down 2 % about 9 hours ago
Gap Down Partially Closed about 9 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Illumina, Inc. Description

Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation and biological function in North America, Europe, Latin America, the Asia-Pacific, the Middle East, and South Africa. Its sequencing platforms include HiSeq 2000, an instrument for high-throughput sequencing using sequencing by synthesis (SBS) technology; HiSeq 1500 that accommodates lower throughput needs; and MiSeq Personal Sequencing System that offers sequencing applications in a compact and economical instrument for individual researchers. The company's sequencing/array combination platforms comprise HiScanSQ that combines SBS technology and HiScan microarray analysis instrumentation into one system. Its array platforms consist of HiScan and iScan systems that are array scanners, which support the imaging of its array-based genetic analysis products. The company also offers various sample preparation and sequencing kits, such as standard sequencing kits; Infinium assay kits; paired-end genomic deoxyribonucleic acid (DNA) sample prep kits; and TruSeq SBS sequencing kits, as well as library preparation kits. In addition, it provides InfiniumHD Whole-Genome BeadChips, which are multi-sample DNA analysis microarrays; HumanOmni5-Quad, HumanOmni2.5, and HumanOmni1S BeadChips; agriculturally relevant genome panels; and iSelect Custom Genotyping BeadChips. Further, it offers CytoChip, a test for the investigation of genetic abnormalities associated with developmental delay or with complex leukemia's; Eco Real-Time polymerase chain reaction system; and sequencing and genotyping services. The company serves genomic research centers, academic institutions, government laboratories, and clinical research organizations, as well as pharmaceutical, biotechnology, agri-genomics, and consumer genomics companies. It sells its products directly and through distributors. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.


Sector: Healthcare
Industry: Diagnostics & Research
Keywords: S&P 500 Biotechnology Life Sciences Biology Nasdaq 100 Acid Imaging Telehealth Molecular Biology Telemedicine Genomics Clinical Research Lab Testing Scanner Genome DNA Sequencing Polymerase Chain Reaction Genotyping Life Science Tools

Is ILMN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 213.91
52 Week Low 89.01
Average Volume 1,601,684
200-Day Moving Average 139.27
50-Day Moving Average 132.31
20-Day Moving Average 126.51
10-Day Moving Average 121.66
Average True Range 4.75
RSI (14) 43.50
ADX 12.67
+DI 22.93
-DI 24.08
Chandelier Exit (Long, 3 ATRs) 125.83
Chandelier Exit (Short, 3 ATRs) 129.97
Upper Bollinger Bands 139.34
Lower Bollinger Band 113.68
Percent B (%b) 0.36
BandWidth 20.28
MACD Line -3.60
MACD Signal Line -3.44
MACD Histogram -0.1647
Fundamentals Value
Market Cap 19.51 Billion
Num Shares 159 Million
EPS -7.35
Price-to-Earnings (P/E) Ratio -16.72
Price-to-Sales 5.05
Price-to-Book 3.81
PEG Ratio 3.79
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 128.75
Resistance 3 (R3) 128.72 126.73 127.77
Resistance 2 (R2) 126.73 125.23 126.75 127.44
Resistance 1 (R1) 124.80 124.31 123.81 124.83 127.12
Pivot Point 122.81 122.81 122.31 122.83 122.81
Support 1 (S1) 120.88 121.31 119.89 120.91 118.62
Support 2 (S2) 118.89 120.39 118.91 118.30
Support 3 (S3) 116.96 118.89 117.97
Support 4 (S4) 116.99